Skip to content
Preprint · OA via OpenAlex

The role of Cycloastragenol at the intersection of Nrf-2/ARE, telomerase, and proteasome activity

Sinem Yılmaz, Erdal Bedіr, Petek Ballar

bioRxiv (Cold Spring Harbor Laboratory) · 2022 · ▲ 1 citations

Abstract

Abstract Aging is well-characterized by the gradual decline of cellular functionality. As redox balance, proteostasis(definition), and telomerase systems have been found to be associated with aging and age-related diseases, targeting these systems by small compounds has been considered as a promising therapeutic approach. Cycloastragenol (CA), a small molecule telomerase activator obtained from Astragalus species, has been reported to have positive effects on several age-related pathophysiologies, including ischemia, glucose intolerance, diabetes, and neurodegenerative diseases. Although CA has received intense attention as a promising compound for aging and age-related diseases, the mechanisms underlying CA activity related to redox balance, proteasome, and telomerase has not yet been reported. Here, we presented that CA increased Nrf-2 activity leading to upregulation of cytoprotective enzymes and attenuation of oxidative stress-induced ROS levels. Furthermore, CA enhanced telomerase activity by increasing not only the expression of hTERT but also its nuclear localization via the Hsp90-chaperon complex. CA alleviated the oxidative stress-induced mitochondrial hTERT levels while increasing the nuclear hTERT levels. Additionally, the proteasome activity and assembly were increased by CA. Strikingly, our data revealed that CA-mediated neuroprotection requires both Nrf-2 and hTERT induction. In conclusion, this study is the first report describing the effect of CA on these aging-related three major cellular pathways and their interrelationships. As the proteasome activator effect of CA is dependent on induction of telomerase activity, which is mediated by Nrf-2 system, CA has a great potential for healthier aging and prevention or treatment of age-related diseases by positively affecting these three cellular pathways.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1101/2022.03.11.483898
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Yılmaz, S., Bedіr, E., &amp; Ballar, P. (2022). The role of Cycloastragenol at the intersection of Nrf-2/ARE, telomerase, and proteasome activity. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2022.03.11.483898
Vancouver
Yılmaz S, Bedіr E, Ballar P. The role of Cycloastragenol at the intersection of Nrf-2/ARE, telomerase, and proteasome activity. bioRxiv (Cold Spring Harbor Laboratory). 2022. doi:10.1101/2022.03.11.483898.
BibTeX
@unpublished{sinem2022Therol, title = {The role of Cycloastragenol at the intersection of Nrf-2/ARE, telomerase, and proteasome activity}, author = {Sinem Yılmaz and Erdal Bedіr and Petek Ballar}, journal = {bioRxiv (Cold Spring Harbor Laboratory)}, year = {2022}, doi = {10.1101/2022.03.11.483898}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings